Label: BLT 3- tetracaine ointment

  • NDC Code(s): 70372-729-01
  • Packager: CENTURA PHARMACEUTICALS INC
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 4, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Tetracaine 2%

  • PURPOSE

    Topical Anesthetic

  • USES

    For the temporary relief of pain and itching.

  • WARNINGS

    • For external use only.
    • Avoid contact with eyes or mucus membranes.
    • Do not apply to open or damaged skin.
    • If condition worsens or symptoms persist for
    more than seven days, discontinue use and
    consult physician.
    • If pregnant or breast feeding,contact physician
    prior to use.
    • Keep out of reach of children. If swallowed,
    contact Poison Control Center.
    • Do not use if allergic to any ingredient in ointment.
    • Do not use in large quantities, particularly over
    raw surfaces or blistered areas.

  • DIRECTIONS

    Adults and children two-years of age or
    older: Apply to affected area not more than three to
    four times daily. Children under two-years of age:
    consult a physician.

  • OTHER INFORMATION

    Store below 77° F (25° C). Avoid
    direct sunlight.

  • INACTIVE INGREDIENTS

    Aqua (Deionized Water), PEG-8 Stearate, PEG-100 Stearate, PEG8, PEG-75,Methylisothiazolinone

  • KEEP OUT OF REACH OF CHILDREN

  • PACKAGE LABELING

    BLT3

  • INGREDIENTS AND APPEARANCE
    BLT 3 
    tetracaine ointment
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70372-729
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    TETRACAINE (UNII: 0619F35CGV) (TETRACAINE - UNII:0619F35CGV) TETRACAINE2 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    PEG-100 STEARATE (UNII: YD01N1999R)  
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    POLYETHYLENE GLYCOL 3350 (UNII: G2M7P15E5P)  
    METHYLISOTHIAZOLINONE (UNII: 229D0E1QFA)  
    PEG-8 STEARATE (UNII: 2P9L47VI5E)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70372-729-015 g in 1 POUCH; Type 0: Not a Combination Product10/30/2016
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01710/30/2016
    Labeler - CENTURA PHARMACEUTICALS INC (084921637)
    Registrant - CENTURA PHARMACEUTICALS INC (084921637)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!